Anti-breast cancer activity of biosynthesized selenium nanoparticles using Bacillus coagulans supernatant

被引:9
作者
Khaledizade, Elaheh [1 ]
Tafvizi, Farzaneh [1 ]
Jafari, Parvaneh [2 ]
机构
[1] Islamic Azad Univ, Dept Biol, Parand Branch, Parand, Iran
[2] Islamic Azad Univ, Fac Sci, Microbiol Dept, Arak Branch, Arak, Iran
关键词
Bacillus coagulans; Apoptosis; Cell cycle arrest; Selenium nanoparticles; Green synthesize; SODIUM SELENITE; ANTICANCER ACTIVITY; GREEN SYNTHESIS; INDUCTION; APOPTOSIS; CELLS; EXTRACT; POLYSACCHARIDE; TOXICITY; NANORODS;
D O I
10.1016/j.jtemb.2023.127357
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: In the present study, Selenium Nanoparticles (SeNPs) were prepared using Bacillus coagulans, which is a type of Lactic Acid Bacteria (LAB), and then they were applied to treat breast cancer cells. Methods: The chemicophysical properties of the bioengineered SeNPs were investigated by Transmission Electron Microscopy (TEM), Field Emission Scanning Electron Microscopy (FE-SEM), zeta potential, dynamic light scattering, Fourier Transform Infrared Spectroscopy (FT-IR), energy dispersive X-ray spectroscopy (EDX) and X-ray diffraction analysis (XRD). The cytotoxic potential of SeNPs was evaluated by MTT assay against MCF-7 breast cancer cell line. The expression levels of apoptotic genes including BAX, BCL2, VEGF, ERBB2, CASP3, CASP9, CCNE1, CCND1, MMP2 and MMP9 were determined by real-time PCR. The rate of apoptosis and necrosis of the cancer cells as well as the results of the cell cycle were evaluated by flow cytometry method. Results: The synthesized SeNPs had an average particle size of about 24-40 nm and a zeta potential of -16.1 mV, indicating the high stability of SeNPs. EDX results showed presence of SeNPs because amount of selenium in SeNPs was 86.6 % by weight. The cytotoxicity results showed a concentration-dependent effect against MCF-7 cells. The half-maximal inhibitory concentration (IC50) values of B. coagulans supernatant and SeNPs against breast cancer cells were 389.7 mu g/mL and 17.56 mu g/mL, respectively. In addition, SeNPs synthesized by the green process exhibited enhanced apoptotic potential in MCF-7 cancer cells compared with bacterial supernatants. Cancer cells treated with IC50 concentration of SeNPs induced 32 % apoptosis compared to untreated cells (3 % apoptosis). The gene expression levels of BAX, CASP3, and CASP9 were upregulated, while the expression levels of BCL2, CCNE1, CCND1, MMP2, MMP9, VEGF, and ERBB2 were downregulated after SeNPs treatment of cells. The potential of SeNPs to induce cell apoptosis was demonstrated by the increase in the expression level of BAX gene and the decrease in the expression level of BCL2 after treatment of cancer cells with SeNPs. Conclusion: The obtained results indicated that SeNPs had strong potential to induce significant cell apoptosis and are cytotoxic against the MCF-7 cancer cell line.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Tracing the pathways and mechanisms involved in the anti-breast cancer activity of glycyrrhizin using bioinformatics tools and computational methods
    Poustforoosh, Alireza
    Faramarz, Sanaz
    Negahdaripour, Manica
    Tuzun, Burak
    Hashemipour, Hassan
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (02) : 819 - 833
  • [22] Anti-breast cancer activity of Fine Black ginseng (Panax ginseng Meyer) and ginsenoside Rg5
    Kim, Shin-Jung
    Kim, An Keun
    JOURNAL OF GINSENG RESEARCH, 2015, 39 (02) : 125 - 134
  • [23] Biosynthesized selenium nanoparticles: characterization, antimicrobial, and antibiofilm activity against Enterococcus faecalis
    Miglani, Sanjay
    Tani-Ishii, Nobuyuki
    PEERJ, 2021, 9
  • [24] Novel quercetin encapsulated chitosan functionalized copper oxide nanoparticles as anti-breast cancer agent via regulating p53 in rat model
    Elsayed, Awny M.
    Sherif, Naglaa M.
    Hassan, Nahla S.
    Althobaiti, Fayez
    Hanafy, Nemany A. N.
    Sahyon, Heba A.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 185 : 134 - 152
  • [25] Boesenbergia Pandurata as an Anti-Breast Cancer Agent: Molecular Docking and ADMET Study
    Pratama, Mohammad Rizki Fadhil
    Praditapuspa, Ersanda Nurma
    Kesuma, Dini
    Poerwono, Hadi
    Widiandani, Tri
    Siswodihardjo, Siswandono
    LETTERS IN DRUG DESIGN & DISCOVERY, 2022, 19 (07) : 606 - 626
  • [26] Characterization and biological activity of selenium nanoparticles biosynthesized by Yarrowia lipolytica
    Lashani, Elham
    Moghimi, Hamid
    Turner, Raymond J.
    Amoozegar, Mohammad Ali
    MICROBIAL BIOTECHNOLOGY, 2024, 17 (10):
  • [27] Atranorin, an antimicrobial metabolite from lichen Parmotrema rampoddense exhibited in vitro anti-breast cancer activity through interaction with Akt activity
    Harikrishnan, Adhikesavan
    Veena, V.
    Lakshmi, B.
    Shanmugavalli, R.
    Theres, Sonia
    Prashantha, C. N.
    Shah, Tanya
    Oshin, K.
    Togam, Ringu
    Nandi, Sisir
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (04) : 1248 - 1258
  • [28] Design and synthesis of chromone-nitrogen mustard derivatives and evaluation of anti-breast cancer activity
    Sun, Jianan
    Mu, Jiahui
    Wang, Shenglin
    Jia, Cai
    Li, Dahong
    Hua, Huiming
    Cao, Hao
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 431 - 444
  • [29] The palladacycle, BTC2, exhibits anti-breast cancer and breast cancer stem cell activity
    Kimani, Serah
    Chakraborty, Suparna
    Irene, Ikponmwosa
    de la Mare, Jo
    Edkins, Adrienne
    du Toit, Andre
    Loos, Ben
    Blanckenberg, Angelique
    Van Niekerk, Annick
    Costa-Lotufo, Leticia, V
    ArulJothi, K. N.
    Mapolie, Selwyn
    Prince, Sharon
    BIOCHEMICAL PHARMACOLOGY, 2021, 190
  • [30] Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
    Ferro, Claudio
    Matos, Ana I.
    Serpico, Luigia
    Fontana, Flavia
    Chiaro, Jacopo
    D'Amico, Carmine
    Correia, Alexandra
    Koivula, Risto
    Kemell, Marianna
    Gaspar, Maria Manuela
    Acurcio, Rita C.
    Cerullo, Vincenzo
    Santos, Helder A.
    Florindo, Helena F.
    ADVANCED HEALTHCARE MATERIALS, 2025, 14 (05)